Nona Biosciences and MedUni Vienna Collaborate on Infectious Diseases
CAMBRIDGE, Massachusetts, July 23, 2026 Nona Biosciences has announced a strategic research collaboration with the Medical University of Vienna...
Immunotherapy
Advertisement
Alpha Tau Medical Ltd. Reports Positive Head and Neck Cancer Results
JERUSALEM, July 21, 2026 Alpha Tau Medical Ltd. announced positive clinical study results evaluating its Alpha DaRT® (Diffusing Alpha-emitters...
City of Hope Launches Phase 2 Lung Cancer Biomarker Trial
LOS ANGELES, July 21, 2026 City of Hope has launched the national Phase 2 IMMUNO-BIOMAP clinical trial to better...
Pheast Therapeutics Publishes New PHST001 Oncology Research
REDWOOD CITY, Calif., July 21, 2026 Pheast Therapeutics announced the publication of peer-reviewed preclinical data in Clinical Cancer Research,...
Oncolytics Biotech Wins FDA Fast Track for Pelareorep
SAN DIEGO, July 20, 2026 Oncolytics Biotech announced that the U.S. Food and Drug Administration (FDA) has granted Fast...
Advertisements
VERAXA Achieves Key Regulatory Milestone for BiTAC-TCE
ZURICH, Switzerland, July 20, 2026 VERAXA Biotech AG (NASDAQ: VRXA) announced that it has received Scientific Advice from Germany’s...
CoRegen Wins FDA IND Clearance for CRG-150
HOUSTON, July 7, 2026 CoRegen, Inc. has received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) clearance...
FDA Grants EUA for Ivermectin to Prevent Horse Screwworm
SILVER SPRING, Md., July 15, 2026 The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...
HERVolution Reports HERV-K Findings in Obesity Research
COPENHAGEN, Denmark & NEW YORK, USA, July 15, 2026 HERVolution Therapeutics ApS, a biotechnology company developing human endogenous retrovirus...
GSK Completes Nuvalent Acquisition to Expand Lung Cancer
LONDON, July 16, 2026 GSK plc has officially completed its acquisition of Nuvalent, Inc., marking a major strategic expansion...
Advertisement
